Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (5)
  • 2024 (4)
  • 2023 (6)
  • 2022 (2)
  • 2021 (3)
  • 2019 (2)

Subject

  • Drug Trafficking (32)
  • Take Back Day (26)
  • Outreach/Drug Prevention (23)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Synthetic drugs (14)
  • Fake Pills (13)
  • Congressional Affairs (12)
  • Major Law Enforcement Operation (11)
  • Press Conferences (11)
  • Arrests/Convictions - Major (10)
  • Diversion Division (10)
  • Fentanyl Awareness (10)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Red Ribbon (9)
  • Guns/Weapons (8)
  • One Pill Can Kill (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Money Laundering (6)
  • OCDETF/Task Force (5)
  • Overdose (5)
  • Seizures (Drugs/Property) (5)
  • Extraditions (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Fentanyl Free America (3)
  • Gangs (3)
  • Campaigns (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Prescription Drugs (23)

Drug Name

  • Oxycodone (4)
  • Fentanyl (2)
  • Methamphetamine (2)
  • Cocaine (1)
  • GHB (1)
  • Heroin (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Opioids (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (35)
  • Seattle (25)
  • New England (24)
  • Atlanta (19)
  • Miami (19)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
  • Sede (23)
Clear All Results
23 Results - Showing 21 to 23
PRESS RELEASE

DEA Finalizes Measures to Expand Medication-Assisted Treatment

WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially in rural areas where those suffering with opioid use disorder may have limited treatment options. Under the final rule published today, DEA registrants who are authorized to dispense methadone...
PRESS RELEASE

Pharmaceutical distributor and executives, pharmacists charged with unlawfully distributing painkillers

CINCINNATI – A federal grand jury has charged a pharmaceutical distributor, two of its former officials and two pharmacists with conspiring to distribute controlled substances in an indictment returned here yesterday. Four individuals have been charged, including Miami-Luken’s former president and compliance officer and two West Virginia pharmacists. Those charged...
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Page 2
  • Current page 3
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster